We identified a frameshift variant in CYBA in one family and a splice site variant in TRPM4 in another family; while the genes encode proteins in diverse pathways, their functions appeared to converge in intestinal-barrier integrity and mucus-biology-targeting inflammatory bowel disease, a known risk factor of CRC [14]. This evidence concerns the gene TRPM4 and colorectal carcinoma.